Chemed (CHE) Gains from Investment Securities (2009 - 2026)

Chemed's Gains from Investment Securities history runs 18 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 427.4% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $2.1 million (up 140.57% YoY), while the FY2025 annual figure was $888000.0, up 201.02% from the prior year.
• Gains from Investment Securities was $1.5 million for Q1 2026 at Chemed, up from -$7.6 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $12.4 million in Q3 2022 to a low of -$11.6 million in Q4 2022.
• Historically, Gains from Investment Securities has averaged $818750.0 across 5 years, with a median of $881500.0 in 2025.
• The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities sank 1657.51% in 2022, then jumped 6337.59% in 2024.
• A 5-year view of Gains from Investment Securities shows it stood at -$11.6 million in 2022, then soared by 135.38% to $4.1 million in 2023, then sank by 307.54% to -$8.5 million in 2024, then gained by 10.97% to -$7.6 million in 2025, then soared by 119.51% to $1.5 million in 2026.
• The last three Gains from Investment Securities figures came in at $1.5 million (Q1 2026), -$7.6 million (Q4 2025), and $8.2 million (Q2 2025), per Business Quant data.